These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Use of recombinant bovine somatotropin for up to two consecutive lactations on dairy production traits.
    Author: McBride BW, Burton JL, Gibson JP, Burton JH, Eggert RG.
    Journal: J Dairy Sci; 1990 Nov; 73(11):3248-57. PubMed ID: 2273151.
    Abstract:
    Fifteen (control) cows were injected with saline; 28 cows were treated with rbST (15 with 10.3 and 13 with 20.6 mg/d). Fourteen of the 28 treated cows had between injected with rbST in the previous lactation. A total of 29 cows in the present trial had not received rbST in previous lactation. Treatment injections were started between wk 4 and 5 of lactation and continued for 266 consecutive days. Milk production, fee intake and efficiency, and BW data were recorded for 3 wk before and 3 wk after a 38-wk rbST treatment period. Administration of rbST increased average FCM yields in the current lactation by 19%, increased feed energy intake by 7%, and decreased feed conversion (energy intake per unit FCM output) by 17%. Previous treatment with rbST did not significantly affect current milk production but caused a nonsignificant increase in feed intake and a significant, unfavorable, increase in feed conversion of 12%. The results suggest that the advantages of rbST in terms of increased milk yield are maintained for a second consecutive lactation of rbST administration. However, the advantages of rbST in terms of improved feed conversion may be substantially reduced in a second consecutive lactation of administration.
    [Abstract] [Full Text] [Related] [New Search]